Published in Ann Pediatr Endocrinol Metab on June 30, 2016
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 2.38
Hypercalcemia in acute lymphoblastic leukemia: an overview. J Pediatr Hematol Oncol (2009) 1.76
Hypercalcemia complicating childhood malignancies. Cancer (1993) 1.72
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia (2006) 1.56
Hypercalcemia in children presenting with acute lymphoblastic leukemia. Int J Hematol (1997) 1.18
Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab (2012) 1.13
Hypercalcemia in children and adolescents. Curr Opin Pediatr (2010) 1.09
Hypercalcemia and childhood cancer: a 7-year experience. J Pediatr Hematol Oncol (2005) 1.07
Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders. Br J Haematol (2010) 1.05
Severe hypercalcemia as a form of acute lymphoblastic leukemia presentation in children. Rev Bras Ter Intensiva (2016) 1.00
PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia. Pediatr Blood Cancer (2007) 0.92
Hypercalcaemia with disseminated osteolytic lesions: a rare presentation of childhood acute lymphoblastic leukaemia. Ecancermedicalscience (2015) 0.92
Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. N Am J Med Sci (2015) 0.90
Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature. J Pediatr Endocrinol Metab (2014) 0.89
The use of bisphosphonates in pediatrics. Horm Res Paediatr (2014) 0.87
Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag (2015) 0.85
Investigation and management of hypercalcaemia in children. Arch Dis Child (2012) 0.80
Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience. J Clin Endocrinol Metab (2015) 0.79